Algifor Dolo Rhinogrippal 200 mg / 30 mg, gélules

7680682640010 CH-68264 Kapseln

Associated product:

ALGIFOR Dolo Rhinogrippal caps 20 pce
Algifor Dolo Rhinogrippal 200 mg / 30 mg, gélules
google

Article details

Package size
20
Selling units
20
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/03/2025
Patient information leaflet
Français
19/03/2025
Patient information leaflet
Italien
19/03/2025
Summary of Product Characteristics
Allemand
12/03/2025
Summary of Product Characteristics
Français
12/03/2025
Summary of Product Characteristics
Italien
12/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FIMDK
(N/A)
1.19 MG Substance HBESI

Authorization holder

Verfora SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
68264
Drug name
Algifor Dolo Rhinogrippal, gélules
Galenic form
KAHA
ATC Code
M01AE51
Authorization status
Z
Dispensing category
D
First authorization
21/01/2022
Authorization expiration date
20/01/2027
IT Number
07.10.2.
Domain
Human medicine

Package details

Description (FR)
ALGIFOR Dolo Rhinogrippal caps 20 pce
Description (DE)
ALGIFOR Dolo Rhinogrippal Kaps 20 Stk
Market launch
21/01/2022
Narcotic (BTM)
No

Other package sizes (1)

None
2 KAP
GTIN: None
Not in V1